This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its (R)-configuration makes it particularly valuable in the development of enantiomerically pure drugs, where the specific stereochemistry is crucial for biological activity. It is often employed in the production of antidepressants, antipsychotics, and other central nervous system (CNS) drugs. Additionally, it serves as an intermediate in the synthesis of compounds targeting serotonin and dopamine receptors, contributing to the treatment of neurological and psychiatric disorders. Its fluorophenyl group enhances binding affinity and selectivity in drug-receptor interactions, making it a key component in medicinal chemistry research and drug development.